Trisomie 18: Hoe lethaal is ‘lethaal’?

Marije A. Brouwer; Els L.M. Maeckelberghe; Mark A.H.B.M. Van Der Hoeven; Joan Schutte; Hsiang Ling Wee; Christine Willekes; A. A.E.Eduard Verhagen

Trisomie 18: Hoe lethaal is ‘lethaal’?

Marije A. Brouwer^*, Els L.M. Maeckelberghe, Mark A.H.B.M. Van Der Hoeven, Joan Schutte, Hsiang Ling Wee, Christine Willekes, A. A.E.Eduard Verhagen

^*Bijbehorende auteur voor dit werk

Onderzoeksoutput › Academic › peer review

2 Citaten (Scopus)

4 Downloads (Pure)

Samenvatting

Should active treatment be available for children with trisomy 18? In the Netherlands, trisomy 18 is described as a lethal condition leading to death during or immediately after birth. The Dutch course of action for trisomy 18 is termination of pregnancy, almost without exception, or passive treatment without medical interventions. But that approach might be outdated. We present a case that inspired physicians and parents to rethink the perception of trisomy 18.

Vertaalde titel van de bijdrage	Trisomy 18: How lethal is 'lethal'?
Originele taal-2	Dutch
Artikelnummer	D1716
Aantal pagina's	3
Tijdschrift	Nederlands Tijdschrift voor Geneeskunde
Volume	161
Nummer van het tijdschrift	0
Status	Published - 2017

Toegang tot document

Trisomie 18: hoe letaal is ‘letaal’?Final publisher's version, 153 KBLicentie: Taverne

https://www.ntvg.nl/artikelen/trisomie-18-hoe-letaal-letaal

Handle.net

Permanente koppeling

Citeer dit

@article{0594e767847042039d7ef5da2e482532,

title = "Trisomie 18: Hoe lethaal is {\textquoteleft}lethaal{\textquoteright}?",

abstract = "Should active treatment be available for children with trisomy 18? In the Netherlands, trisomy 18 is described as a lethal condition leading to death during or immediately after birth. The Dutch course of action for trisomy 18 is termination of pregnancy, almost without exception, or passive treatment without medical interventions. But that approach might be outdated. We present a case that inspired physicians and parents to rethink the perception of trisomy 18.",

keywords = "English Abstract, Journal Article",

author = "Brouwer, {Marije A.} and Maeckelberghe, {Els L.M.} and {Van Der Hoeven}, {Mark A.H.B.M.} and Joan Schutte and Wee, {Hsiang Ling} and Christine Willekes and Verhagen, {A. A.E.Eduard}",

year = "2017",

language = "Dutch",

volume = "161",

journal = "Nederlands Tijdschrift voor Geneeskunde",

issn = "0028-2162",

publisher = "NLM (Medline)",

number = "0",

}

TY - JOUR

T1 - Trisomie 18

T2 - Hoe lethaal is ‘lethaal’?

AU - Brouwer, Marije A.

AU - Maeckelberghe, Els L.M.

AU - Van Der Hoeven, Mark A.H.B.M.

AU - Schutte, Joan

AU - Wee, Hsiang Ling

AU - Willekes, Christine

AU - Verhagen, A. A.E.Eduard

PY - 2017

Y1 - 2017

N2 - Should active treatment be available for children with trisomy 18? In the Netherlands, trisomy 18 is described as a lethal condition leading to death during or immediately after birth. The Dutch course of action for trisomy 18 is termination of pregnancy, almost without exception, or passive treatment without medical interventions. But that approach might be outdated. We present a case that inspired physicians and parents to rethink the perception of trisomy 18.

AB - Should active treatment be available for children with trisomy 18? In the Netherlands, trisomy 18 is described as a lethal condition leading to death during or immediately after birth. The Dutch course of action for trisomy 18 is termination of pregnancy, almost without exception, or passive treatment without medical interventions. But that approach might be outdated. We present a case that inspired physicians and parents to rethink the perception of trisomy 18.

KW - English Abstract

KW - Journal Article

M3 - Article

C2 - 29171368

SN - 0028-2162

VL - 161

JO - Nederlands Tijdschrift voor Geneeskunde

JF - Nederlands Tijdschrift voor Geneeskunde

IS - 0

M1 - D1716

ER -